{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:38:01Z","timestamp":1794865081975,"version":"4.9.1"},"reference-count":66,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Molec Gen &amp; Gen Med"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ovarian cancer is one of the most common gynecological malignancies. Due to the absence of effective screening methods, ovarian cancer is usually diagnosed at late stages. Patients with pathogenic and likely\u2010pathogenic germline variants (PGVs) in <jats:italic>BRCA1<\/jats:italic> or <jats:italic>BRCA2<\/jats:italic> harbor elevated risk of developing both ovarian and breast cancers. Identifying PGVs may help in both cancer prevention and active disease treatment. Worldwide prevalence of PGVs varies and the matter is poorly addressed among Arab patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with epithelial ovarian, fallopian tube or primary peritoneal cancers were offered the universal 20 or 84\u2010multi\u2010gene panel testing as per standard guidelines. Cascade family screening was also offered to all first and second\u2010degree relatives of PGV positive patients. Genetic testing was done at a referral lab using a next generation sequencing (NGS)\u2010based platform.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the study period, 152 patients, median age (range): 50 (18\u201379) years old, were tested. The majority (<jats:italic>n<\/jats:italic>\u00a0=\u2009100, 65.8%) had high\u2010grade serous carcinoma, and 106 patients (69.7%) had metastatic disease at presentation. In total, 38 (25.0%) had PGVs, while 47 (30.9%) others had variants of uncertain significance (VUS). PGVs were mostly in <jats:italic>BRCA1<\/jats:italic> (<jats:italic>n<\/jats:italic>\u00a0=\u200921, 13.8%) and in <jats:italic>BRCA2<\/jats:italic> (<jats:italic>n<\/jats:italic>\u00a0=\u200912, 7.9%), while 6 (3.9%) others had PGVs in non\u2010<jats:italic>BRCA1\/2<\/jats:italic> genes<jats:italic>.<\/jats:italic> PGV rates were significantly higher among 15 patients with a positive family history of ovarian cancer (60.0%, <jats:italic>p<\/jats:italic>\u00a0=\u2009.022) and among 52 patients with a positive family history of breast cancer (40.4%, <jats:italic>p<\/jats:italic>\u00a0=\u2009.017).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PGVs are common among Jordanian women with ovarian cancer, and mostly occur in <jats:italic>BRCA1\/2<\/jats:italic>. Given its clinical impact on disease prevention and precision therapy, universal testing should be routinely offered.<\/jats:p><\/jats:sec>","DOI":"10.1002\/mgg3.2125","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:42:25Z","timestamp":1671522145000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (<scp>Jo\u2010ECAG<\/scp>) ovarian study"],"prefix":"10.1002","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-6051","authenticated-orcid":false,"given":"Hikmat","family":"Abdel\u2010Razeq","sequence":"first","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"},{"name":"Department of Internal Medicine the University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khansa","family":"Al\u2010Azzam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha","family":"Elemian","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Abu\u2010Fares","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Abu Sheikha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Bani Hani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Bater","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha\u2019","family":"Sharaf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie","family":"Heald","sequence":"additional","affiliation":[{"name":"Invitae  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Esplin","sequence":"additional","affiliation":[{"name":"Invitae  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Invitae  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mais","family":"Alkyam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Abujamous","sequence":"additional","affiliation":[{"name":"Department of Cell Therapy &amp; Applied Genomic King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Al\u2010Attary","sequence":"additional","affiliation":[{"name":"Department of Nursing King Hussein Cancer Center  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8362179","article-title":"Patterns and prevalence of germline BRCA1 and BRCA2 mutations among high\u2010risk breast cancer patients in Jordan: A study of 500 patients","volume":"2020","author":"Abdel\u2010Razeq H.","year":"2020","journal-title":"Journal of Oncology"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.3048"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.009"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09094-8"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02772-y"},{"issue":"10","key":"e_1_2_11_7_1","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck A.","year":"1998","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32176"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041059"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00277-7"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.09.030"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42703"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174344"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3233\/BD-130348"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.6314"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30676"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13970"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.2781"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001"},{"key":"e_1_2_11_22_1","article-title":"TRACEBACK: Testing of historical Tubo\u2010ovarian cancer patients for hereditary risk genes as a cancer prevention strategy in family members","volume":"9","author":"Delahunty R.","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.11.014"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1555"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09181-4"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1684\/bdc.2014.2049"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16975"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23965"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1295-428"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910962"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.721"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00051"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01262-2"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.24.2869"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s007950300002"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2020.1820466"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-016-9919-z"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01854"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1940"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.14735\/amko2019S51"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030416"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000558"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00174-5"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-022-00213-5"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5495"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001261"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001556"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2009.02.001"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911361"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn442"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60149-5"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23736"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.08.017"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.48095\/ccko202126"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2019.7984"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2699"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.3.719"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01924"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02434-6"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00615-3"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115052108"},{"issue":"3","key":"e_1_2_11_65_1","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population\u2010based\u2010case\u2010control studies of ovarian cancer","volume":"60","author":"Whittemore A. S.","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1456"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.01.020"}],"container-title":["Molecular Genetics &amp; Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mgg3.2125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mgg3.2125","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mgg3.2125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:10:30Z","timestamp":1692655830000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mgg3.2125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1002\/mgg3.2125"],"URL":"https:\/\/doi.org\/10.1002\/mgg3.2125","archive":["Portico"],"relation":{},"ISSN":["2324-9269","2324-9269"],"issn-type":[{"value":"2324-9269","type":"print"},{"value":"2324-9269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"2022-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2125"}}